SCHEMBL3064583

SCHEMBL3064583

CCCCc1cc(Cn2c(=O)n(Cc3cc(CCCC)c(O)c(CCCC)c3)c(=O)n(Cc3cc(CCCC)c(O)c(CCCC)c3)c2=O)cc(CCCC)c1O

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 1/20 0.40
▸ TYR P14679 1/20 0.40
▸ ALOX5 P09917 4/20 0.38
▸ MAOA P21397 1/20 0.38
▸ MAPK1 P28482 2/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ PTGS2 P35354 3/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ GAA P10253 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ ERAP1 Q9NZ08 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21289229 0.90 BACE1 (0.41) TYRALOX5HPGDALDH1A1GAA
SCHEMBL12457244 0.87 TYR (0.48) TYRALOX5HTTPTGS2ALDH1A1
SCHEMBL13951478 0.86 EGFR (0.33) EGFRTYRALOX5MAOAMAPK1
SCHEMBL21569772 0.85 TYR (0.42) EGFRTYRALOX5HTTPTGS2
SCHEMBL8147251 0.85 HCAR2 (0.38) EGFRALDH1A1KDM4EMEN1KMT2A
SCHEMBL10928445 0.82 GPR84 (0.39) ALOX5NPSR1ALDH1A1KDM4E
SCHEMBL20615288 0.82 BACE1 (0.45) TYRALOX5MAPK1NPC1HPGD
SCHEMBL201692 0.79 NPC1 (0.57) EGFRTYRALOX5MAPK1NPC1
SCHEMBL3254496 0.79 KDM4E (0.42) EGFRTYRALOX5MAOAMAPK1
SCHEMBL31055825 0.79 KDM4E (0.42) EGFRTYRALOX5MAOAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114058114-A Nucleated polypropylene resin for primary lens packages 强生视力健公司 2022-02-18 — — CN claimed
EP-0553498-A2 Additive composition for improved stability of poly(4-methyl-1-pentene) PHILLIPS PETROLEUM COMPANY (US) 1993-08-04 — — EP claimed
US-20230374267-A1 LIGHT STABILIZER MASTERBATCH AND PRODUCTION METHOD FOR POLYPROPYLENE-BASED RESIN COMPOSITION USING SAME ADEKA CORPORATION (JP) 2023-11-23 — — US disclosed
US-20220108815-A1 TWISTED WIRE AND CABLE INCLUDING THE SAME YAZAKI CORPORATION (JP) 2022-04-07 — — US disclosed
CN-114058114-A Nucleated polypropylene resin for primary lens packages 强生视力健公司 2022-02-18 — — CN disclosed
US-20210139694-A1 POLYESTER POLYMER COMPOSITIONS SOLVAY SPECIALITY POLYMERS USA, LLC 2021-05-13 — — US disclosed
US-10703902-B2 Polycarbonate resin composition and molded body thereof MITSUBISHI CHEMICAL CORPORATION (JP) 2020-07-07 — — US disclosed
EP-3357971-A1 POLYCARBONATE RESIN COMPOSITION AND MOLDED ARTICLE OF SAME Mitsubishi Chemical Corporation (JP) 2018-08-08 — — EP disclosed
US-20180208764-A1 POLYCARBONATE RESIN COMPOSITION AND MOLDED BODY THEREOF MITSUBISHI CHEMICAL CORPORATION (JP) 2018-07-26 — — US disclosed
EP-2216336-B1 PROCESS FOR PRODUCTION OF CYCLIC POLYORGANOSILOXANE, CURING AGENT, CURABLE COMPOSITION, AND CURED PRODUCT OF THE CURABLE COMPOSITION KANEKA CORP (JP) 2015-11-04 — — EP disclosed
US-20120287499-A1 FILM MIRROR, METHOD FOR PRODUCING SAME, AND SUNLIGHT REFLECTING MIRROR KONICA MINOLTA ADVANCED LAYERS, INC. (JP) 2012-11-15 — — US disclosed
US-20120268811-A1 FILM MIRROR, METHOD FOR PRODUCING SAME, AND REFLECTING DEVICE FOR SOLAR THERMAL POWER GENERATION USING SAID FILM MIRROR KONICA MINOLTA ADVANCED LAYERS, INC. (JP) 2012-10-25 — — US disclosed
US-8273842-B2 Process for production of cyclic polyorganosiloxane, curing agent, curable composition, and cured product of the curable composition KANEKA CORPORATION (JP) 2012-09-25 — — US disclosed
US-20100267919-A1 PROCESS FOR PRODUCTION OF CYCLIC POLYORGANOSILOXANE, CURING AGENT, CURABLE COMPOSITION, AND CURED PRODUCT OF THE CURABLE COMPOSITION KANEKA CORPORATION (JP) 2010-10-21 — — US disclosed
EP-2216336-A1 PROCESS FOR PRODUCTION OF CYCLIC POLYORGANOSILOXANE, CURING AGENT, CURABLE COMPOSITION, AND CURED PRODUCT OF THE CURABLE COMPOSITION Kaneka Corporation (JP) 2010-08-11 — — EP disclosed
US-20050124750-A1 Synthetic resin composition and bearing parts made therefrom MINEBEA CO., LTD. (JP) 2005-06-09 — — US disclosed
EP-0553498-A2 Additive composition for improved stability of poly(4-methyl-1-pentene) PHILLIPS PETROLEUM COMPANY (US) 1993-08-04 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267919-A1 PROCESS FOR PRODUCTION OF CYCLIC POLYORGANOSILOXANE, CURING AGENT, CURABLE COMPOSITION, AND CURED PRODUCT OF THE CURABLE COMPOSITION SMCHD1, SQLE, SMARCA5 EGFR 4324/4885TYR 3574/4885ALOX5 88/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback